Extracorporeal Support of Liver Function (II Part)

Kiley J. , Welch H.F. , Pender J.C. Removal of blood ammonia by hemodialysis. Proc Soc Exp Biol Med 1956; 91: 489–90.

Davenport A. , Will E.J. Losowsky MS. Rebound surges of intracranial pressure as a consequence of forced ultrafiltration used to control intracranial pressure in patients with severe hepatorenal failure. Am J Kidney Dis 1989; 14: 516–9.

Yatzidis H. A convenient hemoperfusion microapparatus over charcoal for the treatment of endogenous and exogenous intoxification: Its use as an effective artificial kidney. Proc Eur Dial Transplant Assoc 1964; 1: 83–7.

Tetta C. , Cavaillon J.M. , Camussi G. Continuous plasma filtration coupled with sorbents. Kidney Int 1998; (suppl) 66: S186–9.

Trey M.B. , Bums D.G. , Saunders S.J. Treatment of hepatic coma by exchange blood transfusion. N Engl J Med 1966; 42: 394–8.

Santoro A. , Mancini E. Bilirubina ed acidi biliari: tossicità e rimozione. In: Cappelli P. , Amoroso L. , di Liberato L. , eds. Aferesi Terapeutica. Bios Editorial 2003: pp. 179–2.

Stange J. , Hassanein T.I. , Mehta R. , Mitzner S.R. , Bartlett R.H. The molecular adsorbents recycling system as a live support system based on albumin dialysis: A summary of preclinical investigations, prospective randomised, controlled clinical trial and clinical experience from 19 centers. Artif Organs 2002; 26: 103.

Stange J. , Mitzer S. , Klammt S. New extracorporeal liver support for chronic liver disease complicated by cholestasis-result of a prospective randomized two center trial. J Hepatol 2001: 34–45.

Ichai P. , Samuel D. Extracorporeal liver support with MARS in liver failure: has it a role in the treatment of severe alcoholic hepatitis? J Hepatol 2003; 38: 104–6.

Strobl W. , Vogt G. , Mitteregger R. Das “Fractionated Plasma Separation and Adsorption System” (FPSA), ein neues membran-adsorptionsgestütztes adjubktives extrakorporales Blutreinigungssystem für das Leberversagen; Biomedizinische Technik, Band 43, Ergänzungsband 1998; 1: 168–9.

Falkenhagen D. , Strobl W. , Vogt G. Fractionated plasma separation and adsorption system: A novel system for blood purification to remove albumin bound substances. Int J Artif Organs 1999; 23: 81–6.

Krause A. Prometheus - a new extracorporeal liver support therapy. In: Arroyo V. , Forns X. , Garcia-Pagán J.C. , Rodés J. , eds. Progress in the treatment of liver diseases. Ars Medica 2003: pp. 437–43.

Herget-Rosenthal S. , Treichel U. , Saner F. Citrate anti-coagulated modified fractionated plasma separation and adsorption: first clinical efficacy and safety data in liver failure. ASN 2003.

Kramer L. , Bauer E. , Schenk P. Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus). Wien Klin Wochenschr 2003; 115: 599–603.

Lange R. , Vacanti P. Tissue engineering: The design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 1999; (suppl) 354: S32–4.

Sussman N.L. , Kelly J.H. Artificial liver supports. Clin Invest Med 1996; 19: 393–9.

McLaughlin B.E. , Tosone C.M. , Custer L.M. , Mullon C. Overview of extracorporeal liver support systems and clinical results. Ann NY Acad Sci 1999: pp. 310–25.

Sukhikh G.T. , Shtil A.A. Stem cell transplantation for treatment of liver diseases: From biological foundations to clinical experience. Int J Mol Med 2003; 11: 395–400.

Allen J.W. , Bhatia S.N. Improving the next generation of bioartificial liver devices. Sem Cell Develop Biol 2002; 13: 447–54.

Millis J.M. , Cronic D.C. , Johnson R. Initial experience with the modified extracorporeal liver assist device for patients with fulminant hepatic failure: System modifications and clinical impact. Transplantation 2002; 27: 1735–46.

Gerlach J.C. , Encke J. , Hole O. Bioreactor for a larger scale hepatocyte in vitro perfusion. Transplantation 1994; 58: 984–8.

Morsiani E. , Broghi M. , Galavotti D. Biological liver support, optimal cell source and cell mass. Int J Artif Organs 2002; 25: 985.

Hammer C. Xenotransplantation for liver therapy. Can porcine hepatocytes generate physiological functions sufficient for a human patient in ALF? Int J Artif Organs 2002; 25: 1019.

Nyberg S.L. , Rimmel R.P. , Man H.J. Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartifical liver. Ann Surg 1994; 220: 59–67.

Kobayashi N. , Miyazaki M. , Fukaya K. Establishment of a highly differentiated immortalized human hepatocytes cell line as a source of hepatic function in the bioartificial liver. Transplant Proc 2000; 32: 237–41.

Maguire P.J. , Stevens S. , Shander A. Bioartificial organ support for hepatic, renal, and hematologic failure. Crit Care Clin 2000; 16: 681–94.

Sussman N.L. , Gislason G.T. , Conlin C.A. , Kelly J.H. The hepatic extracorporeal liver assist device - initial clinical experience. Artif Organs 1994; 18: 390–6.

Kobayashi N. , Noguchi H. , Fujiwara T. , Tanaka N. Establishment of reversibly immortalized human hepatocyte cell line by using Cre/LoxP site-specific recombination. Transplant Proc 2000; 32: 1121–2.

Michalopoulos G.K. , De Frances M.C. Liver regeneration. Science 1997; 276: 60–6.

Fausto N. Liver regeneration. Hepatology 2000; 32: 19–31.

Rhim J.A. , Sandren E.P. , Degen J.L. Replacement of diseased mouse liver by hepatic cell transplantation. Science 1994; 263: 1149–52.

Overturf K. , Al-Dhalimy M.M. , Tanguay R. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of heriditary tyrosinaemia type I. Nat Genet 1996; 12: 266–73.

Sirica A.E. , Mathias G.A. , Sano N. , Elmore L.W. Isolation, culture and transplantation of intra-hepatic biliary epithelial cells and oval cells. Pathobiology 1990; 58: 44–64.

Fausto N. Hepatic regeneration. In: Hepatology: A textbook of liver diseases. Pennsylvania: W.B. Saunders Co., 1996; 1: 32–58.

Rambhatla L. , Chiu C.P. , Kundu P. , Peng Y. , Carpenter M.K. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant 2003; 12: 1–11.

Commission of the European Community, March 2002.

Theise N.D. , Badve S. , Saxena R. , Henegarini O. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000; 1: 235–40.

Lagasse E. Hepatic regeneration from hematopoietic stem cells. Mech Dev 2003; 120: 131–5.

Wang J.X. , Willenbring H. , Akkari Y. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003; 422: 897–901.

Terada H. , Hamazaki T. , Hoki M. , Mastalerz D.M. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416: 542–5.

Spees J.L. , Olson S.D. , Ylastalo J. , Lynch P.J. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci USA 2003; 100: 2397–402.

Patzer J.F. Oxygen consumption in a hollow fiber bioartificial liver-revisited. Artif Organs 2004; 28: 83–98.

Obermayer N. , Busse B. , Grunwald A. Biochemical characterization of bioreactors for hybrid liver support: Serum-free liver cell coculture of nonparenchymal and parenchymal cells. Transplant Proc 2001; 33: 1930–1.

Kim S.S. , Utsunomiya H. , Koski J.A. Survival and function of hepatocytes on a novel three dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann Surg 1998; 228: 8–13.